ETFMG Treatments Testing & Adv ETF (NY:GERM)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 19.16 |
| Bid (Size) | 9.600 (1) |
| Ask (Size) | 21.77 (1) |
| Prev. Close | 19.16 |
| Today's Range | 19.16 - 19.16 |
| 52wk Range | N/A - N/A |
| Shares Outstanding | 5,000 |
| Dividend Yield | 0.92% |
Top News
More News
Performance
More News
Read More
Biotech ETFs That Outperformed Last Week ↗
December 20, 2021
5 Best Sector ETFs of November ↗
December 01, 2021
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone ↗
November 01, 2021
ETFs to Buy on Most-Bullish Wall Street Outlook in Two Decades ↗
August 16, 2021
Tuesday Talk: Summer Stock ↗
July 06, 2021
5 Sector ETFs That Crushed The Market In April ↗
May 01, 2021
5 Niche ETFs Dominating the Current Market Rally ↗
April 20, 2021
Frequently Asked Questions
Is ETFMG Treatments Testing & Adv ETF publicly traded?
Yes, ETFMG Treatments Testing & Adv ETF is publicly traded.
What exchange does ETFMG Treatments Testing & Adv ETF trade on?
ETFMG Treatments Testing & Adv ETF trades on the New York Stock Exchange
What is the ticker symbol for ETFMG Treatments Testing & Adv ETF?
The ticker symbol for ETFMG Treatments Testing & Adv ETF is GERM on the New York Stock Exchange
What is the current price of ETFMG Treatments Testing & Adv ETF?
The current price of ETFMG Treatments Testing & Adv ETF is 19.16
When was ETFMG Treatments Testing & Adv ETF last traded?
The last trade of ETFMG Treatments Testing & Adv ETF was at 09/05/24 08:00 PM ET
What is the market capitalization of ETFMG Treatments Testing & Adv ETF?
The market capitalization of ETFMG Treatments Testing & Adv ETF is 95.79K
How many shares of ETFMG Treatments Testing & Adv ETF are outstanding?
ETFMG Treatments Testing & Adv ETF has 96K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.